Long-Term Effectiveness of Scleral Lens Treatment in the Management of Keratoconus: A Systematic Review

医学 圆锥角膜 视力 科克伦图书馆 梅德林 生活质量(医疗保健) 眼科 验光服务 随机对照试验 外科 角膜 护理部 政治学 法学
作者
Adeel Mushtaq,Isaamuddin Alvi
出处
期刊:Cureus [Cureus, Inc.]
被引量:1
标识
DOI:10.7759/cureus.77102
摘要

This systematic review evaluates the long-term effectiveness of scleral lenses in improving visual outcomes, patient satisfaction, and safety in patients with keratoconus. A systematic search of six databases (PubMed, Embase, Web of Science, Scopus, Cochrane Library, and MEDLINE) was performed following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The inclusion criteria included studies with more than or equal to three months of follow-up, included a minimum of 20 keratoconus patients, published after year 2020 and outcomes reporting visual acuity, comfort or quality of life. Methodological quality was assessed using the Newcastle-Ottawa Scale and Murad et al. case series tool. Five studies (463 eyes) met the inclusion criteria. Scleral lenses consistently improved best-corrected visual acuity (BCVA) across studies, with visual gains from baseline logMAR 0.50-0.53 to post-treatment logMAR 0.08-0.09. Significant improvements in vision-related quality of life (National Eye Institute Visual Function Questionnaire (NEI-VFQ) scores) were observed in validated assessments. Complications were infrequently reported but included lens handling issues (10.4%-63%), fogging (58%), and physiological events (e.g., corneal epitheliopathy). Long-term follow-up indicated that 14.6% of the patients experienced worsening visual acuity due to keratoconus progression. Methodological quality was variable, with limitations including variable outcome reporting and limited follow-up duration. Scleral lenses provide substantial and sustained improvements in visual acuity and quality of life for keratoconus patients, particularly those with advanced disease. However, the evidence is limited by methodological shortcomings and a lack of long-term controlled studies. Future research should prioritise randomised trials with standardised reporting and longer follow-up to better assess complications and durability of outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
赘婿应助科研通管家采纳,获得10
刚刚
奔跑的青霉素完成签到 ,获得积分10
1秒前
Rye227应助科研通管家采纳,获得10
1秒前
Lucas应助科研通管家采纳,获得10
1秒前
乐乐应助科研通管家采纳,获得10
1秒前
1秒前
小巧念露完成签到,获得积分10
1秒前
4秒前
酷波er应助xiaomili采纳,获得10
4秒前
KD发布了新的文献求助10
5秒前
5秒前
6秒前
123发布了新的文献求助10
6秒前
6秒前
tudou发布了新的文献求助10
7秒前
9秒前
贾克斯发布了新的文献求助10
10秒前
KD完成签到,获得积分20
11秒前
11秒前
11秒前
12秒前
xiaomili发布了新的文献求助10
13秒前
xiaomili发布了新的文献求助10
13秒前
Akim应助123采纳,获得10
14秒前
15秒前
xiaomili发布了新的文献求助10
15秒前
xiaomili发布了新的文献求助10
15秒前
执着乐双发布了新的文献求助30
17秒前
17秒前
18秒前
扎心发布了新的文献求助10
20秒前
Akim应助开心的若烟采纳,获得10
20秒前
汉堡包应助阳光绝山采纳,获得10
21秒前
19854173750发布了新的文献求助10
22秒前
夏夏周发布了新的文献求助10
22秒前
23秒前
ALIVE_STAR完成签到,获得积分10
25秒前
口腔飞飞完成签到 ,获得积分10
28秒前
打打应助小龙采纳,获得10
28秒前
大模型应助19854173750采纳,获得10
29秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Encyclopedia of Geology (2nd Edition) 2000
Maneuvering of a Damaged Navy Combatant 650
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
Mixing the elements of mass customisation 300
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
Nucleophilic substitution in azasydnone-modified dinitroanisoles 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3780200
求助须知:如何正确求助?哪些是违规求助? 3325511
关于积分的说明 10223282
捐赠科研通 3040677
什么是DOI,文献DOI怎么找? 1668962
邀请新用户注册赠送积分活动 798897
科研通“疑难数据库(出版商)”最低求助积分说明 758634